Exelixis | EXEL - Dönen Varlıklar





Dönen Varlıklar Değişiklik Tarih
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 27.97B 1.65B 2026-06
Bayer EUR 35.3B 2.39B 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Cytokinetics USD 839.46M 77.51M 2026-03
Eisai JPY 761.64B 79.24B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
Glaxosmithkline GBP 17.76B 5.83B 2026-03
Incyte USD 6.03B 542.31M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
MacroGenics USD 182.52M 37.42M 2026-03
Merck USD 35.02B 8.5B 2026-03
Moderna USD 5.82B 45M 2026-06
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 42.82B 76M 2026-03
Puma Biotechnology USD 143.58M 7M 2025-09
Sanofi EUR 30.16B 789M 2026-03
Takeda JPY 3.15T 59.77B 2026-06
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Xencor USD 482.85M 116.97M 2026-03